Evidence map›Paper›PMID 35654846›Full record

ArticleNature chemical biology2022

Detection of cell-cell interactions via photocatalytic cell tagging.

Rob C Oslund, Tamara Reyes-Robles, Cory H White, Jake H Tomlinson, Kelly A Crotty, Edward P Bowman, Dan Chang, Vanessa M Peterson, Lixia Li, Silvia Frutos and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. AbioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 2 countries.

Rob C OslundMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA. rob@induprolabs.com.ORCID http://orcid.org/0000-0002-2920-9532
Tamara Reyes-RoblesMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA. tamara.reyes.robles@merck.com.ORCID http://orcid.org/0000-0001-7753-7971
Cory H WhiteMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.
Jake H TomlinsonMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.
Kelly A CrottyMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-8462-5275
Edward P BowmanDiscovery Research, Merck & Co., Inc., San Francisco, CA, USA.
Dan ChangGenetics and Pharmacogenomics, Merck & Co., Inc., Boston, MA, USA.
Vanessa M PetersonGenetics and Pharmacogenomics, Merck & Co., Inc., Boston, MA, USA.
Lixia LiGenetics and Pharmacogenomics, Merck & Co., Inc., Boston, MA, USA.
Silvia FrutosSpliceBio, Barcelona, Spain.
Miquel Vila-PerellóSpliceBio, Barcelona, Spain.
David VlerickAblynx, A Sanofi Company, Zwijnaarde, Belgium.
Karen CromieAblynx, A Sanofi Company, Zwijnaarde, Belgium.
David H PerlmanMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.
Sampat IngaleMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.
Samantha D O' HaraMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.
Lee R RobertsMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.
Grazia PiizziMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.
Erik C HettMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.
Daria J HazudaMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.
Olugbeminiyi O FadeyiMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA. niyi@induprolabs.com.ORCID http://orcid.org/0000-0002-5525-1304
Merck & Co., Inc., Rahway, NJ, USA (United States) · USAblynx (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing appreciation of immune cell-cell interactions within disease environments has led to extensive efforts to develop immunotherapies. However, characterizing complex cell-cell interfaces in high resolution remains challenging. Thus, technologies leveraging therapeutic-based modalities to profile intercellular environments offer opportunities to study cell-cell interactions with molecular-level insight. We introduce photocatalytic cell tagging (PhoTag) for interrogating cell-cell interactions using single-domain antibodies (VHHs) conjugated to photoactivatable flavin-based cofactors. Following irradiation with visible light, the flavin photocatalyst generates phenoxy radical tags for targeted labeling. Using this technology, we demonstrate selective synaptic labeling across the PD-1/PD-L1 axis in antigen-presenting cell-T cell systems. In combination with multiomics single-cell sequencing, we monitored interactions between peripheral blood mononuclear cells and Raji PD-L1 B cells, revealing differences in transient interactions with specific T cell subtypes. The utility of PhoTag in capturing cell-cell interactions will enable detailed profiling of intercellular communication across different biological systems.

Indexed as

B7-H1 AntigenLeukocytes, MononuclearCell CommunicationFlavinsImmunotherapyB7-H1 AntigenFlavins

Identifiers

PMID35654846
OpenAlexW4281700719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.